CVS Group plc (LON:CVSG – Get Free Report) insider David Wilton acquired 2,500 shares of the firm’s stock in a transaction on Tuesday, December 2nd. The stock was purchased at an average price of GBX 1,219 per share, with a total value of £30,475.
CVS Group Trading Down 1.3%
LON CVSG opened at GBX 1,218 on Wednesday. The business’s fifty day moving average is GBX 1,265.93 and its 200-day moving average is GBX 1,249.18. The company has a debt-to-equity ratio of 110.52, a current ratio of 1.09 and a quick ratio of 0.90. The stock has a market capitalization of £872.04 million, a price-to-earnings ratio of 16.55, a PEG ratio of 1.77 and a beta of 1.02. CVS Group plc has a one year low of GBX 800 and a one year high of GBX 1,648.
CVS Group (LON:CVSG – Get Free Report) last posted its quarterly earnings data on Tuesday, October 7th. The company reported GBX 80.10 earnings per share (EPS) for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. Equities research analysts predict that CVS Group plc will post 93.9393939 EPS for the current year.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on CVSG
About CVS Group
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Read More
- Five stocks we like better than CVS Group
- Canadian Penny Stocks: Can They Make You Rich?
- The $100 Million Tell: Following Smart Money Into DoorDash
- When to Sell a Stock for Profit or Loss
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- Investing In Automotive Stocks
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
